Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 225

Cited In for PubMed (Select 17240289)

1.

Prediction of Metabolic Gene Biomarkers for Neurodegenerative Disease by an Integrated Network-Based Approach.

Ni Q, Su X, Chen J, Tian W.

Biomed Res Int. 2015;2015:432012. doi: 10.1155/2015/432012. Epub 2015 May 3.

2.

Coexistence of Gait Disturbances and Chorea in Experimental Huntington's Disease.

Casaca-Carreira J, Temel Y, van Zelst M, Jahanshahi A.

Behav Neurol. 2015;2015:970204. doi: 10.1155/2015/970204. Epub 2015 May 6.

3.

Rescue of αB Crystallin (HSPB5) Mutants Associated Protein Aggregation by Co-Expression of HSPB5 Partners.

Hussein RM, Benjamin IJ, Kampinga HH.

PLoS One. 2015 May 11;10(5):e0126761. doi: 10.1371/journal.pone.0126761. eCollection 2015.

4.

Transgenic animal models for study of the pathogenesis of Huntington's disease and therapy.

Chang R, Liu X, Li S, Li XJ.

Drug Des Devel Ther. 2015 Apr 15;9:2179-88. doi: 10.2147/DDDT.S58470. eCollection 2015. Review.

5.

Current perspectives on deep brain stimulation for severe neurological and psychiatric disorders.

Kocabicak E, Temel Y, Höllig A, Falkenburger B, Tan SKh.

Neuropsychiatr Dis Treat. 2015 Apr 9;11:1051-66. doi: 10.2147/NDT.S46583. eCollection 2015. Review.

6.

Dexmedetomidine with low-dose ketamine for cataract surgery under peribulbar block in a patient with Huntington's chorea.

Naik S, Shetti AN, Nadkarni AV, Ahuja B.

Anesth Essays Res. 2015 Jan-Apr;9(1):92-4. doi: 10.4103/0259-1162.150140.

7.

Conditional targeting of medium spiny neurons in the striatal matrix.

Reinius B, Blunder M, Brett FM, Eriksson A, Patra K, Jonsson J, Jazin E, Kullander K.

Front Behav Neurosci. 2015 Mar 27;9:71. doi: 10.3389/fnbeh.2015.00071. eCollection 2015.

8.

Neural stem cells could serve as a therapeutic material for age-related neurodegenerative diseases.

Suksuphew S, Noisa P.

World J Stem Cells. 2015 Mar 26;7(2):502-11. doi: 10.4252/wjsc.v7.i2.502. Review.

9.

Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.

Ciechanover A, Kwon YT.

Exp Mol Med. 2015 Mar 13;47:e147. doi: 10.1038/emm.2014.117. Review.

10.

Roles of ubiquitination and SUMOylation on prostate cancer: mechanisms and clinical implications.

Chen Z, Lu W.

Int J Mol Sci. 2015 Feb 27;16(3):4560-80. doi: 10.3390/ijms16034560. Review.

11.

Intermediate phenotypes and biomarkers of treatment outcome in major depressive disorder.

Leuchter AF, Hunter AM, Krantz DE, Cook IA.

Dialogues Clin Neurosci. 2014 Dec;16(4):525-37.

12.

Reduction in subventricular zone-derived olfactory bulb neurogenesis in a rat model of Huntington's disease is accompanied by striatal invasion of neuroblasts.

Kandasamy M, Rosskopf M, Wagner K, Klein B, Couillard-Despres S, Reitsamer HA, Stephan M, Nguyen HP, Riess O, Bogdahn U, Winkler J, von Hörsten S, Aigner L.

PLoS One. 2015 Feb 26;10(2):e0116069. doi: 10.1371/journal.pone.0116069. eCollection 2015.

13.

Impact of air pollutants on oxidative stress in common autophagy-mediated aging diseases.

Numan MS, Brown JP, Michou L.

Int J Environ Res Public Health. 2015 Feb 17;12(2):2289-305. doi: 10.3390/ijerph120202289.

14.

A review of creatine supplementation in age-related diseases: more than a supplement for athletes.

Smith RN, Agharkar AS, Gonzales EB.

F1000Res. 2014 Sep 15;3:222. doi: 10.12688/f1000research.5218.1. eCollection 2014. Review.

15.

Trinucleotide repeats and haplotypes at the huntingtin locus in an Indian sample overlaps with European haplogroup a.

Moily NS, Kota LN, Anjanappa RM, Venugopal S, Vaidyanathan R, Pal P, Purushottam M, Jain S, Kandasamy M.

PLoS Curr. 2014 Sep 24;6. pii: ecurrents.hd.a3ad1a381ab1eed117675145318c9a80. doi: 10.1371/currents.hd.a3ad1a381ab1eed117675145318c9a80.

16.

Untargeted metabolic profiling identifies interactions between Huntington's disease and neuronal manganese status.

Kumar KK, Goodwin CR, Uhouse MA, Bornhorst J, Schwerdtle T, Aschner M, McLean JA, Bowman AB.

Metallomics. 2015 Feb;7(2):363-70. doi: 10.1039/c4mt00223g.

PMID:
25599126
17.

Spinal cord atrophy in early Huntington's disease.

Mühlau M, Engl C, Boucard CC, Schmidt P, Biberacher V, Görsch I, Sorg C, Wohlschläger A, Zimmer C, Hemmer B, Weindl A.

Ann Clin Transl Neurol. 2014 Apr;1(4):302-6. doi: 10.1002/acn3.52. Epub 2014 Mar 24.

18.

Pleomorphic Invasive Ductal Carcinoma of the Breast in a Patient with Huntington's Disease.

Shousha S.

Case Rep Pathol. 2014;2014:979137. doi: 10.1155/2014/979137. Epub 2014 Dec 9.

19.

Signature changes in ubiquilin expression in the R6/2 mouse model of Huntington's disease.

Safren N, Chang L, Dziki KM, Monteiro MJ.

Brain Res. 2015 Feb 9;1597:37-46. doi: 10.1016/j.brainres.2014.12.008. Epub 2014 Dec 12.

PMID:
25511991
20.

Supporting physical activity engagement in people with Huntington's disease (ENGAGE-HD): study protocol for a randomized controlled feasibility trial.

Busse M, Quinn L, Dawes H, Jones C, Kelson M, Poile V, Trubey R, Townson J, Edwards RT, Rosser A, Hood K.

Trials. 2014 Dec 12;15:487. doi: 10.1186/1745-6215-15-487.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk